Skip to content

GujjuTicks brief

Gujarat Themis Biosyn completes acquisition of MicroBiopharm Japan Co.

For FY26, MBJ has registered revenue of JPY 9.5 billion ,with a business mix spanning Proprietary APIs/Intermediates, CDMO, CDMO Bio and Developed ... This GujjuTicks brief summarizes the headline for local readers; read the full story on the publisher site.

This is a short GujjuTicks summary for discovery. Full reporting and quotes belong to the original publisher.

Read full story More in Gujarat business Today’s edition